retatrutide phase 2 nejm weight loss 48 weeks triple agonist Peptide Series #3 — 🧬🏃🏻‍♀️ BOOM🔥! The most POWERFUL DRUG EVER tested in a clinical trial isn't approved yet. But the data is already rewriting what we thought was Retatrutide vs. Tirzepatide: The Next-Gen

van Bindsbergen 1 1 Princess Mxima Center for Pediatric Oncology, Utrecht, The Netherlands, 2 Amsterdam UMC Location University of Amsterdam, Emma Childrens Hospital, Child and Adolescent Psychiatry & Psychosocial Care, Amsterdam, The Netherlands, 3 Amsterdam Public Health Research Institute, Methodology, Amsterdam, Netherlands Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :207.1 Aims Each year, approximately 600 children are diagnosed with cancer in the Netherlands, impacting their physical, mental, and social health

J.BaconP

Structural insights into neonatal Fc receptor-based recycling mechanisms

Our results showed the successful isolation of stem cells from a heterogeneous population based on cellular GSH levels without causing detrimental effects to the cells

55,57 These injured or profibrotic tubular cells recruit macrophages, lymphocytes, and fibroblasts, promoting tissue fibrosis and leading to irreversible kidney damage

First, human caSMCs also showed a 2-fold increase in cAMP release in response to GLP-1(2836), which was abolished in the presence of the sAC inhibitor KH7, but not the tmAC inhibitor Ddox (Figure 2H)